4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
12.55
+0.41 (3.38%)
Oct 19, 2026, 12:49 PM EDT - Market open
4D Molecular Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $28 | Buy | Maintains | $28 | +123.11% | Oct 13, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains $25 | Buy | Maintains | $25 | +99.20% | Oct 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 29, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $29 → $33 | Buy | Reiterates | $29 → $33 | +162.95% | Sep 29, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Upgrades n/a | Buy | Upgrades | n/a | n/a | Sep 21, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $35 | Buy | Reiterates | $35 | +178.88% | Aug 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $36 | Buy | Reiterates | $36 | +186.85% | Aug 14, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Initiates $37 | Buy | Initiates | $37 | +194.82% | Jul 31, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.